glp-1 agonist eli lilly Lilly's KwikPen Delivers Month of Zepbound in One Device Eli Lilly stock soars on

It allows Novo to defend its semaglutide franchise while broadening access to patients who prefer oral therapy

By combining lifestyle changes such as a reduced-calorie diet with GLP-1 therapy, patients can achieve modest to significant weight loss and improved cardiovascular outcomes

Nutritionally Yours: Alane Wincek, ND, CNC 11175 Cicero Drive, Suite 100, Alpharetta, GA 30022 Phone: 678-372-2913 Fax: 866-593-1611 Email: [email protected] Metro Atlanta Areas Served: Roswell, Alpharetta, Marietta

10.3390/medicina60030393

by Sarah Muntel, RD Spring 2026 Nutritional needs change throughout life, from childhood to adolescence and into Read Article by Audrey Wells, MD Spring 2026 Obstructive sleep apnea (OSA) and obesity often occur in the same Read Article Your Support Fuels Education Your donation helps OAC create high-quality education that supports real people on their health journeys